ZNF79

gene
On this page

Also known as pT7

Summary

ZNF79 (zinc finger protein 79, HGNC:13153) is a protein-coding gene on chromosome 9q33.3, encoding Zinc finger protein 79 (Q15937). May be involved in transcriptional regulation.

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.

Source: NCBI Gene 7633 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 88 total
  • MANE Select transcript: NM_007135

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:13153
Approved symbolZNF79
Namezinc finger protein 79
Location9q33.3
Locus typegene with protein product
StatusApproved
AliasespT7
Ensembl geneENSG00000196152
Ensembl biotypeprotein_coding
OMIM194552
Entrez7633

Gene structure

Transcript identifiers

Ensembl transcripts: 7 — 6 protein_coding, 1 nonsense_mediated_decay

ENST00000342483, ENST00000543471, ENST00000612342, ENST00000617266, ENST00000850855, ENST00000850856, ENST00000850857

RefSeq mRNA: 5 — MANE Select: NM_007135 NM_001286696, NM_001286697, NM_001286698, NM_001322260, NM_007135

CCDS: CCDS6871, CCDS69664, CCDS75904

Canonical transcript exons

ENST00000342483 — 5 exons

ExonStartEnd
ENSE00001036799127435908127436003
ENSE00001036811127435090127435216
ENSE00001460343127444029127445372
ENSE00001460347127424382127424803
ENSE00003520666127428832127428920

Expression profiles

Bgee: expression breadth ubiquitous, 199 present calls, max score 84.82.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.1494 / max 91.3627, expressed in 1785 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
986078.14941785

Top tissues by expression

270 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047384.82gold quality
tendon of biceps brachiiUBERON:000818884.47gold quality
tendonUBERON:000004377.95gold quality
calcaneal tendonUBERON:000370176.96gold quality
granulocyteCL:000009476.54gold quality
stromal cell of endometriumCL:000225576.24gold quality
amniotic fluidUBERON:000017375.73gold quality
islet of LangerhansUBERON:000000675.60gold quality
medial globus pallidusUBERON:000247775.23gold quality
buccal mucosa cellCL:000233675.09silver quality
muscle of legUBERON:000138374.89gold quality
secondary oocyteCL:000065574.84gold quality
gastrocnemiusUBERON:000138874.78gold quality
hindlimb stylopod muscleUBERON:000425274.44gold quality
apex of heartUBERON:000209873.83gold quality
cortical plateUBERON:000534373.74gold quality
muscle organUBERON:000163073.66gold quality
globus pallidusUBERON:000187573.47gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099173.44gold quality
ganglionic eminenceUBERON:000402372.84gold quality
ventricular zoneUBERON:000305372.81gold quality
right adrenal gland cortexUBERON:003582772.71gold quality
smooth muscle tissueUBERON:000113572.64gold quality
left adrenal glandUBERON:000123472.64gold quality
endothelial cellCL:000011572.58silver quality
leukocyteCL:000073872.31gold quality
right adrenal glandUBERON:000123372.26gold quality
adrenal glandUBERON:000236972.17gold quality
left adrenal gland cortexUBERON:003582572.12gold quality
monocyteCL:000057672.03gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.84

Regulation

Is transcription factor: yes

Downstream targets (CollecTRI)

2 targets.

TargetRegulation
CAT
TICAM2

Upstream regulators (CollecTRI, top): STAT1

miRNA regulators (miRDB)

8 targeting ZNF79, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-498-5P99.7669.641807
HSA-MIR-4687-3P99.4866.41968
HSA-MIR-19A-5P99.3666.931675
HSA-MIR-19B-1-5P99.3667.071669
HSA-MIR-19B-2-5P99.3667.071669
HSA-MIR-6829-5P98.8665.121480
HSA-MIR-477197.4367.69596
HSA-MIR-478588.5362.7163

Cross-species orthologs

0 orthologs

Paralogs (38): ZFX (ENSG00000005889), ZBTB11 (ENSG00000066422), ZFAT (ENSG00000066827), ZFY (ENSG00000067646), ZNF586 (ENSG00000083828), IKZF5 (ENSG00000095574), ZNF419 (ENSG00000105136), ZNF549 (ENSG00000121406), ZSCAN20 (ENSG00000121903), ZNF304 (ENSG00000131845), PRDM15 (ENSG00000141956), ZNF660 (ENSG00000144792), ZNF711 (ENSG00000147180), ZNF773 (ENSG00000152439), ZNF256 (ENSG00000152454), ZNF837 (ENSG00000152475), ZNF691 (ENSG00000164011), ZNF610 (ENSG00000167554), E4F1 (ENSG00000167967), ZNF562 (ENSG00000171466), ZNF561 (ENSG00000171469), ZNF584 (ENSG00000171574), ZIK1 (ENSG00000171649), ZNF570 (ENSG00000171827), ZSCAN2 (ENSG00000176371), ZNF552 (ENSG00000178935), ZNF154 (ENSG00000179909), ZNF792 (ENSG00000180884), ZNF793 (ENSG00000188227), ZNF548 (ENSG00000188785), ZNF418 (ENSG00000196724), ZNF772 (ENSG00000197128), ZNF583 (ENSG00000198440), ZNF480 (ENSG00000198464), ZNF551 (ENSG00000204519), ZNF134 (ENSG00000213762), ZNF587B (ENSG00000269343), ZNF8 (ENSG00000278129)

Protein

Protein identifiers

Zinc finger protein 79Q15937 (reviewed: Q15937)

Alternative names: ZNFpT7

All UniProt accessions (3): Q15937, A0A087X2B0, F5H032

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

RefSeq proteins (5): NP_001273625, NP_001273626, NP_001273627, NP_001309189, NP_009066* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR050527

Pfam: PF00096

UniProt features (19 total): zinc finger region 11, sequence variant 3, sequence conflict 2, chain 1, domain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q15937-F168.950.44

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 57 (showing top): GSE45365_NK_CELL_VS_CD8_TCELL_DN, MODULE_48, MODULE_95, SCGGAAGY_ELK1_02, MGGAAGTG_GABP_B, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MARTENS_TRETINOIN_RESPONSE_DN, SMIRNOV_RESPONSE_TO_IR_6HR_UP, WARTERS_RESPONSE_TO_IR_SKIN, ZWANG_DOWN_BY_2ND_EGF_PULSE, MODULE_163, JNK_DN.V1_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, BANP_TARGET_GENES, CREB3L4_TARGET_GENES

GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355), positive regulation of transcription by RNA polymerase II (GO:0045944)

GO Molecular Function (7): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), transcription cis-regulatory region binding (GO:0000976), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transcription by RNA polymerase II2
regulation of transcription by RNA polymerase II2
regulation of DNA-templated transcription1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
positive regulation of DNA-templated transcription1
transcription cis-regulatory region binding1
chromatin1
RNA polymerase II transcription regulatory region sequence-specific DNA binding1
DNA-binding transcription factor activity1
transition metal ion binding1
transcription regulatory region nucleic acid binding1
sequence-specific double-stranded DNA binding1
nucleic acid binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

526 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF79COL5A1P20908752
ZNF79OR2AG1Q9H205669
ZNF79ACVRL1P37023590
ZNF79ENGP17813587
ZNF79BMPR2Q13873546
ZNF79TFPIP10646542
ZNF79Q6IQ01Q6IQ01469
ZNF79ADCY10Q96PN6401
ZNF79ZNF77Q15935391
ZNF79DEF8Q6ZN54335
ZNF79OR8G1Q15617320
ZNF79RNF112Q9ULX5300
ZNF79HSD17B10Q99714294
ZNF79C11orf24Q96F05292
ZNF79OR51F1A6NGY5287

IntAct

29 interactions, top by confidence:

ABTypeScore
ZNF79TRIM27psi-mi:“MI:0915”(physical association)0.560
MDFIZNF79psi-mi:“MI:0915”(physical association)0.560
ZNF79psi-mi:“MI:0915”(physical association)0.560
ZNF79psi-mi:“MI:0915”(physical association)0.560
TRIM27ZNF79psi-mi:“MI:0915”(physical association)0.560
KRTAP10-8ZNF79psi-mi:“MI:0915”(physical association)0.560
KRT34ZNF79psi-mi:“MI:0915”(physical association)0.560
KRTAP6-3ZNF79psi-mi:“MI:0915”(physical association)0.560
ZBTB24ZNF79psi-mi:“MI:0915”(physical association)0.560
FGF12ZNF79psi-mi:“MI:0915”(physical association)0.560
YJU2BZNF79psi-mi:“MI:0915”(physical association)0.560
ZNF79IPO8psi-mi:“MI:0914”(association)0.350
ZNF79KRTAP10-8psi-mi:“MI:0915”(physical association)0.000
ZNF79KRTAP6-3psi-mi:“MI:0915”(physical association)0.000
ZNF79KRT34psi-mi:“MI:0915”(physical association)0.000
FGF12ZNF79psi-mi:“MI:0915”(physical association)0.000
ZBTB24ZNF79psi-mi:“MI:0915”(physical association)0.000
ZNF79YJU2Bpsi-mi:“MI:0915”(physical association)0.000

BioGRID (13): ZNF79 (Two-hybrid), ZNF79 (Two-hybrid), KRTAP10-3 (Two-hybrid), ZNF79 (Affinity Capture-RNA), ZNF79 (Affinity Capture-RNA), ZNF79 (Affinity Capture-MS), ZNF79 (Two-hybrid), ZNF79 (Two-hybrid), ZNF79 (Two-hybrid), ZNF79 (Two-hybrid), ZNF79 (Two-hybrid), KRTAP6-3 (Two-hybrid), ZNF79 (Negative Genetic)

ESM2 similar proteins: A0A087WUV0, A0JNB1, A2VDP4, B2RUI1, P0CG31, P10072, P17025, P17036, P17097, P18733, P51814, Q08ER8, Q09FC8, Q0VGE8, Q14590, Q15937, Q16600, Q2M3X9, Q4V8A8, Q5CZA5, Q5R8G9, Q5RBX0, Q5VIY5, Q68DI1, Q6J6I6, Q6NX49, Q6P1L6, Q6PG37, Q6ZMS4, Q6ZMW2, Q80YP6, Q86UD4, Q86Y25, Q8IZ26, Q8N184, Q8NB42, Q8NEK5, Q8TAF7, Q8TF47, Q8WXB4

Diamond homologs: B1H2Q6, G5EGB2, O15535, O75290, P17026, P18724, P18741, P18747, P52742, Q15937, Q17895, Q1LZC0, Q3MJ62, Q4R7X8, Q5R4X5, Q6A085, Q7Z3I7, Q8BGV5, Q8TBZ5, Q91VW9, Q969J2, Q9BRR0, Q9ERU2, Q9ERU3, Q9UEG4, Q9Z1D9, Q9Z2K3, A8MQ14, P17097, P21506, Q03936, Q29RZ4, Q3KNS6, Q3V080, Q5RBX0, Q5RBY9, Q5T619, Q6DD87, Q6J6I6, Q6PG37

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

88 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance76
Likely benign3
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1295 predictions. Top by Δscore:

VariantEffectΔscore
9:127424671:G:GTdonor_gain1.0000
9:127428830:A:AGacceptor_gain1.0000
9:127428831:G:GAacceptor_gain1.0000
9:127428831:GTA:Gacceptor_gain1.0000
9:127428831:GTACT:Gacceptor_gain1.0000
9:127435088:A:AGacceptor_gain1.0000
9:127435088:AG:Aacceptor_gain1.0000
9:127435088:AGG:Aacceptor_gain1.0000
9:127435089:G:Aacceptor_loss1.0000
9:127435089:G:GGacceptor_gain1.0000
9:127435089:GG:Gacceptor_gain1.0000
9:127435089:GGG:Gacceptor_gain1.0000
9:127435191:A:Tdonor_gain1.0000
9:127435213:CTAGG:Cdonor_loss1.0000
9:127435214:TAGG:Tdonor_loss1.0000
9:127435215:AGG:Adonor_loss1.0000
9:127435216:GGTA:Gdonor_loss1.0000
9:127435217:G:Adonor_loss1.0000
9:127435218:T:Gdonor_loss1.0000
9:127435901:T:Aacceptor_gain1.0000
9:127435905:TAG:Tacceptor_loss1.0000
9:127435905:TAGGA:Tacceptor_gain1.0000
9:127435906:A:AGacceptor_gain1.0000
9:127435906:A:ATacceptor_loss1.0000
9:127435906:AG:Aacceptor_gain1.0000
9:127435907:G:GGacceptor_gain1.0000
9:127435907:GG:Gacceptor_gain1.0000
9:127435907:GGA:Gacceptor_gain1.0000
9:127435907:GGAC:Gacceptor_gain1.0000
9:127436004:G:GCdonor_loss1.0000

AlphaMissense

3318 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
9:127444892:T:CF398L0.999
9:127444894:C:AF398L0.999
9:127444894:C:GF398L0.999
9:127444388:T:CF230L0.998
9:127444390:C:AF230L0.998
9:127444390:C:GF230L0.998
9:127444472:T:CF258L0.998
9:127444474:C:AF258L0.998
9:127444474:C:GF258L0.998
9:127444556:T:CF286L0.998
9:127444558:C:AF286L0.998
9:127444558:C:GF286L0.998
9:127444640:T:CF314L0.998
9:127444642:C:AF314L0.998
9:127444642:C:GF314L0.998
9:127444808:T:CF370L0.998
9:127444810:C:AF370L0.998
9:127444810:C:GF370L0.998
9:127444827:T:CL376P0.998
9:127445060:T:CF454L0.998
9:127445062:T:AF454L0.998
9:127445062:T:GF454L0.998
9:127444506:G:CR269P0.997
9:127444724:T:CF342L0.997
9:127444726:C:AF342L0.997
9:127444726:C:GF342L0.997
9:127444837:T:AH379Q0.997
9:127444837:T:GH379Q0.997
9:127444911:T:CL404P0.997
9:127444304:T:CF202L0.996

dbSNP variants (sampled 300 via entrez): RS1000103421 (9:127444360 C>G,T), RS1000155790 (9:127444589 A>G), RS1000195555 (9:127426031 A>G), RS1000238705 (9:127438283 A>T), RS1000301393 (9:127431519 G>T), RS1000472875 (9:127424659 G>A), RS1000537730 (9:127443673 G>A,C), RS1000631037 (9:127426341 C>G), RS1000860296 (9:127436786 G>A,C), RS1000923222 (9:127431225 T>C), RS1000963194 (9:127424395 C>T), RS1001158167 (9:127443352 C>T), RS1001234325 (9:127424618 G>A), RS1001292640 (9:127437143 G>A), RS1001361136 (9:127430551 C>G,T)

Disease associations

OMIM: gene MIM:194552 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

43 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, increases expression6
Aflatoxin B1increases expression, affects expression3
sodium arseniteincreases expression, affects cotreatment, decreases expression, increases abundance2
Formaldehydedecreases expression, increases expression2
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
GSK-J4decreases expression1
TAK-243increases sumoylation1
triphenyl phosphateaffects expression1
bisphenol Aincreases expression1
tobacco tardecreases expression1
manganese chlorideaffects cotreatment, decreases expression, increases abundance1
ferrous chloridedecreases expression1
cupric oxideincreases expression1
resorcinoldecreases expression1
polyhexamethyleneguanidineaffects expression1
CGP 52608affects binding, increases reaction1
nutlin 3affects cotreatment, increases expression1
abrineincreases expression1
Resveratrolaffects cotreatment, increases expression1
Sunitinibincreases expression1
Leflunomideincreases expression1
Acetaminophenincreases expression1
Air Pollutantsincreases abundance, increases expression1
Arsenicaffects cotreatment, decreases expression, increases abundance1
Camptothecinincreases expression1
Cisplatinincreases expression1
Dactinomycinaffects cotreatment, increases expression1
Doxorubicindecreases expression1
Estradiolaffects expression1
Ethyl Methanesulfonateincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.